Within a couple hours, the bride was doing the limbo under Eby’s walker, and Eby was giving people walker rides all over the ...

Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA breakthrough therapy designation, underway in post-bariatric hypoglycemia (PBH); completion ...

Smith's synthetic voice was created by analyzing old recordings made before his illness, allowing him to regain a voice for his thoughts and communicate in a voice similar to his own.

Brad Smith showed the internet how he edits video with nothing but thought, on the YouTube clip he posted last week. The ...

Golden said painless progressive weakness is the key to recognizing ALS, and although research still has a long way to go, ...

Coya Therapeutics, Inc.’s COYA share price has surged by 12.31%, which has investors questioning if this is right time to ...

A groundbreaking achievement in brain-computer interface technology: an ALS patient uses a Neuralink implant to edit and narrate a YouTube video.

The third patient of Elon Musk's brain computer interface company Neuralink is using the billionaire's foul-mouthed AI ...

Smith is the first non-verbal individual and only the third person globally to receive a Neuralink Brain-Chip Interface (BCI) implant.

The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S.

Clene’s cash and cash equivalents totaled $9.8 million as of March 31, 2025, compared to $12.2 million as of December 31, 2024. Clene expects that its resources as of March 31, 2025, will be ...